Table 1.
Cancer site or type | Relative risk of the overweight/obese BMI category evaluated vs. normal BMI (95% CI) |
---|---|
Myeloid leukemia94 | 0.47 (0.26–0.82) |
Non‐metastatic colorectal65 | 0.52 (0.35–0.77) |
Metastatic melanomaa, 29 | 0.72 (0.57–0.91) |
Lymphoma95 | 0.76 (0.67–0.86) |
Gastric96 | 0.76 (0.59–0.99) |
Renal97 | 0.84 (0.73–0.95) |
Metastatic colorectal28 | ≈0.90 (≈0.85–0.95) |
Among patients treated with targeted therapy